2nd Quarter - Report

AKIN GUMP STRAUSS HAUER & FELD for OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.

Firm
Client
Income
$200,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

The Innovation Act (H.R. 9); Helping Families in Mental Health Crisis Act (H.R. 2646); Mental Health Reform Act of 2015 (H.R. 1945); Mental Health Awareness and Improvement Act (S. 1893)

LobbyistCovered position, as disclosed
HEIDE BAJNRAUH —
JOHN JONAS —
KAREN THIEL —
RICHARD THOMPSON —
ELI TOMAR —
MATTHEW TODD TUTEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1945 (114th), H.R. 9 (114th), S. 1893 (114th), H.R. 2646 (114th)

Health Issues HCR

H.R. 2646, the Helping Families in Mental Health Crisis Act; H.R. 2690, Strengthening Mental Health In Our Communities Act; H.R. 6, 21st Century Cures initiative; S. 481, Improving Regulatory Transparency for New Medical Therapies Act

LobbyistCovered position, as disclosed
HEIDE BAJNRAUH —
JOHN JONAS —
KAREN THIEL —
RICHARD THOMPSON —
ELI TOMAR —
MATTHEW TODD TUTEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6 (114th), H.R. 2690 (114th), S. 481 (114th), H.R. 2646 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.